Clinical trial
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
NCT03560271
Study timeline
Study start (actual)2018-06-18Date precision: day
Registry last updated2019-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
Sponsors & collaborators
Mapped research locations
San AntonioTexas, United States2MiamiFlorida, United States1ClevelandOhio, United States1BirminghamAlabama, United States1OrlandoFlorida, United States1Las VegasNevada, United States1St. PetersburgFlorida, United States1Miami BeachFlorida, United States1Chula VistaCalifornia, United States1Coral GablesFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03560271 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.